Fierce Pharma July 18, 2022
Nick Paul Taylor

Eli Lilly has identified 3D printing as a way to get drugs to specific regions of the gastrointestinal tract, leading it to team up with Triastek to work on the targeted release of molecules in the intestine.

Triastek’s MED 3D printing technology enables it to apply layer upon layer of melted excipients, active pharmaceutical ingredients and blended materials. In doing so, the Chinese biotech could unlock new ways to control drug release. Triastek is applying the technology to its internal pipeline, the two most advanced candidates in which have IND clearance, and using it to support partnered programs.

Lilly sees promise in the technology. The collaboration with Triastek has two parts. Firstly, Lilly will work with its...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Biotechnology, Pharma, Pharma / Biotech, Technology
How 3D Printing Impacts Radiology
Ricoh’s 3D Printing Improves Surgical Accuracy and Safety One Layer at a Time
3D-printed hydrogel enables continuous drug delivery via contact lens
Improved 3D printed blood vessels thanks to bioink with DNA
DNA-based bioink technology enables precise 3D-printing of blood vessels

Share This Article